SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,529.07 -242.65
( -0.33%)

Global Indices

Nasdaq

51,510.98 -338.64
(-0.65%)

Dow Jones

7,705.40 -59.01
(-0.76%)

Hang Seng

65,155.57 -722.05
(-1.10%)

Nikkei 225

10,628.22 -56.66
(-0.53%)

Forex

USD-INR

95.79 -0.10
(-0.10%)

EUR-INR

109.09 0.01
(0.01%)

GBP-INR

126.83 0.01
(0.01%)

JPY-INR

0.61 0.00
(0.68%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506879

INE942C01045

79.7352476

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUJTHEM

106.27

5172.88

EPS(TTM)

Face Value()

Div & Yield %

3.74

0.14

Back

Belding India reports consolidated net loss of Rs 3.20 crore in the June 2026 quarter

Jul 31,2026

Net loss of Belding India reported to Rs 3.20 crore in the quarter ended June 2026 as against net profit of Rs 2.34 crore during the previous quarter ended June 2025. Sales reported to Rs 0.22 crore in the quarter ended June 2026. There were no Sales reported during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0.22	0	0
OPM %	-1727.27	0	-
PBDT	-2.30	0	0
PBT	-4.07	0	0
NP	-3.20	2.34	PL

72,529.07 -242.65 ( -0.33%)

51,510.98 -338.64 (-0.65%)

7,705.40 -59.01 (-0.76%)

65,155.57 -722.05 (-1.10%)

10,628.22 -56.66 (-0.53%)

95.79 -0.10 (-0.10%)

109.09 0.01 (0.01%)

126.83 0.01 (0.01%)

0.61 0.00 (0.68%)